Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Prognostic Value
100%
Molecular Profiling
100%
Early Breast Cancer
100%
Lymphovascular Invasion
100%
Hormone Receptor-positive
100%
Oncotype DX
66%
5-year Survival
22%
Medical Records
11%
High-risk Population
11%
Adjuvant Chemotherapy
11%
Low Risk
11%
Hazard Ratio
11%
Clinical Data
11%
Non-associated
11%
Prognostic Factors
11%
Recurrence Rate
11%
Clinical High Risk
11%
Intermediate Risk
11%
Prognostic Significance
11%
Cox Proportional Hazards
11%
Multigene
11%
Competing Risk Analysis
11%
Overall Survival Analysis
11%
Intermediate-risk Group
11%
Recurrence Score
11%
Invasion Status
11%
ER+ Breast Cancer
11%
Bad Outcomes
11%
Negative Prognostic Factors
11%
Medicine and Dentistry
Breast Cancer
100%
Molecular Profiling
100%
Lymphovascular Invasion
100%
Hormone Receptor
100%
Oncotype DX
66%
Recurrent Disease
33%
Overall Survival
22%
Prognostic Factor
22%
Decision Making
11%
Hazard Ratio
11%
Medical Record
11%
High Risk Population
11%
Recurrence Risk
11%
Survival Analysis
11%
Disease Free Survival
11%
Adjuvant Chemotherapy
11%
Intermediate Risk Population
11%
Estrogen Receptor Positive Breast Cancer
11%
Immunology and Microbiology
Overall Survival
100%
Medical Record
50%
Decision Making
50%
High Risk Population
50%
Disease Free Survival
50%
Intermediate Risk Population
50%